Page 895 - Williams Hematology ( PDFDrive )

870 Part VI: The Erythrocyte <CN>: <CT> PB

40. Yanaga K, Tzakis A, Shimade M, Campbell W, et al: Reversal of hypersplenism follow- 69. Liote F, Angle J, Gilmore N, Osterland CK: Asplenism and systemic lupus erythemato-
ing orthotopic liver transplantation. Ann Surg 210:180, 1989. sus. Clin Rheumatol 14:220, 1995.
41. Al-Salem AH, Qaisaruddin S, Nasserallah Z, et al: Splenectomy in patients with sickle- 70. Jarolim DR: Asplenia and rheumatoid arthritis [letter]. Ann Intern Med 97:61, 1982.
cell disease. Am J Surg 172:254, 1996. 71. Kalhs P, Panzer S, Kletter K, et al: Functional asplenia after bone marrow transplanta-
42. Mohren M, Markman I, Dworschak U, et al: Thromboembolic complications after sple- tion. Ann Intern Med 109:461, 1988.
nectomy for hematologic diseases. Am J Hematol 76:143, 2004. 72. Cuthbert RJ, Iqbal A, Gates A, et al: Functional hyposplenism following allogeneic bone
43. Caprotti R, Porta G, Franciosi C, et al: Laparoscopic splenectomy for hematological marrow transplantation. J Clin Pathol 48:257, 1995.
disorders. Int Surg 83:303, 1998. 73. Stone RW, McDaniel WR, Armstrong EM, et al: Acquired functional asplenia in sarcoi-
44. Bar-Moor JA: Partial splenectomy in Gaucher’s disease. J Pediatr Surg 28:686, 1993. dosis. J Natl Med Assoc 77:930, 1985.
45. Banani SA: Partial dearterialization of the spleen in thalassemia major. J Pediatr Surg 74. Muller AF, Toghill PJ: Splenic function in alcoholic liver disease. Gut 33:1386, 1992.
33:449, 1998. 75. Muller AF, Toghill PJ: Functional hyposplenism in alcoholic liver disease: A toxic effect
46. Stanley P, Shen TC: Partial embolization of the spleen in patients with thalassemia. J of alcohol? Gut 35:679, 1994.
Vasc Interv Radiol 6:137, 1995. 76. Gertz MA, Kyle RA: Hepatic amyloidosis (primary [AL], immunoglobulin light chain):
47. Palsson B, Hallen M, Forsberg AM, Alwmark A: Partial splenic embolization: Long- The natural history in 80 patients. Am J Med 85:73, 1988.
term outcome. Langenbecks Arch Surg 387:421, 2003. 77. Powsner RA, Simms RW, Chudnovsky A, et al: Scintigraphic functional hyposplenism
48. Petersons A, Volrats O, Bernsteins A: The first experience with nonoperative treatment in amyloidosis. J Nucl Med 39:221, 1998.
of hypersplenism in children with portal hypertension. Eur J Pediatr Surg 12:299, 2002. 78. Robinson PJ, Bullen AW, Hall R, et al: Splenic size and functions in adult coeliac dis-
49. Watanabe Y, Todani T, Noda T: Changes in splenic volume after partial splenic embol- ease. Br J Radiol 53:532, 1980.
ization in children. J Pediatr Surg 31:241, 1996. 79. O’Grady JG, Stevens FM, Harding B, et al: Hyposplenism and gluten sensitive enterop-
50. Paulino AC, Reddy AC: Splenic irradiation in the palliation of patients with lymphop- athy. Gastroenterology 87:1316, 1984.
roliferative and myeloproliferative disorders. Am J Hosp Palliat Care 13:32, 1996. 80. Palmer KR, Sherriff SB, Holdsworth CD, et al: Further experience of hyposplenism in
51. Peck-Radosavljevic M, Wichlas M, Zacherl J, et al: Thrombopoietin induces rapid res- inflammatory bowel disease. Q J Med 50:461, 1981.
olution of thrombocytopenia after orthotopic liver transplantation through increased 81. Muller AF, Toghill PJ: Hyposplenism in gastrointestinal disease. Gut 36:165, 1995.
platelet production. Blood 95:795, 2000. 82. Dailey MO, Coleman CN, Kaplan HS: Radiation-induced splenic atrophy in patients
52. Rios R, Sangro B, Herrero I, et al: The role of thrombopoietin in the thrombocytopenia with Hodgkin disease and non-Hodgkin lymphoma. N Engl J Med 302:215, 1990.
of patients with liver cirrhosis. Am J Gastroenterol 100:1311, 2005. 83. Spencer RP, Sziklas JJ, Turner JW: Functional obstruction of splenic blood vessel in
53. Lok S, Kaushansky K, Holly RD, et al: Cloning and expression of murine thrombopoie- adults: A radiocolloid study. Int J Nucl Med Biol 9:208, 1982.
tin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994. 84. Torres J, Bisno AL: Hyposplenism and pneumococcemia. Am J Med 55:851, 1973.
54. de Sauvage FJ, Hass PE, Spencer SD, et al: Stimulation of megakaryocytopoiesis and 85. Cavenagh JD, Joseph AE, Dilly S, Bevan DH: Splenic sepsis in sickle cell disease. Br J
thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994. Haematol 86:187, 1994.
55. McHutchinson JG, Dusheiko G, Shiffman ML, et al: Eltrombopag in patients with cir- 86. Gopal V, Bisno AL: Fulminant pneumococcal infections in “normal” asplenic hosts.
rhosis associated with hepatitis C. N Engl J Med 357:2227, 2007. Arch Intern Med 137:1526, 1977.
56. Afdhal NH, Giannini EG, Tayyab G, et al: Eltrombopag before procedures in patients 87. Konradsen HB, Henrichsen J: Pneumococcal infections in splenectomized children are
with cirrhosis and thrombocytopenia. N Engl J Med 23;367, 2012. preventable. Acta Paediatr Scand 80:423, 1991.
57. Moussa MM, Mowafy N: Preoperative use of romiplostim in thrombocytopenic 88. Corazza GR, Ginaldi L, Zoli G, et al: Howell-Jolly body counting as a measure of splenic
patients with chronic hepatitis C and liver cirrhosis. J Gastroenterol Hepatol 28(2):335, function: A reassessment. Clin Lab Haematol 12:269, 1990.
2013. 89. Holroyde CP, Oski FA, Gardner FH: The “pocked” erythrocytes. N Engl J Med 281:516,
58. Ramos H, Todo S, Kang Y, et al: Liver transplantation without the use of blood prod- 1969.
ucts. Arch Surg 129:528, 1994. 90. Reinhart WH, Chien S: Red cell vacuoles: Their size and distribution under normal
59. Snook NJ, O’Beirne HA, Enright S, et al: Use of recombinant human erythropoietin to conditions and after splenectomy. Am J Hematol 27:265, 1988.
facilitate liver transplantation in a Jehovah’s Witness. Br J Anaesth 76:740,1996. 91. Rutland MD: Correlation of splenic function with the splenic uptake rate of Tc-colloids.
60. Freedman RM, Johnston D, Mahoney MJ, et al: Development of splenic reticuloendo- Nucl Med Commun 13:843, 1992.
thelial function in neonates. J Pediatr 96:466, 1980. 92. Kobel DE, Friedl A, Cerny T, et al: Pneumococcal vaccine in patients with absent or
61. Padmanabhan J, Risemberg HM, Rome RD: Howell-Jolly bodies in the peripheral dysfunctional spleen. Mayo Clin Proc 75:749, 2000.
blood of full-term and premature neonates. Johns Hopkins Med J 132:146, 1973. 93. Ward KM, Celebi JT, Gmyrek R, Grossman ME: Acute infectious purpura fulminans
62. Markus HS, Toghill PJ: Impaired splenic function in elderly people. Age Ageing 20:287, associated with asplenism or hyposplenism. J Am Acad Dermatol 47:493, 2002.
1991. 94. Sumaraju V, Smith LG, Smith SM: Infectious complications in asplenic hosts. Infect Dis
63. Ravaglia G, Forti P, Biagi F, et al: Splenic function in old age. Gerontology 44:91, 1998. Clin North Am 15:551, 2001.
64. Steinberg MH, Gatling RR, Tavassoli M: Evidence of hyposplenism in the presence of 95. Castagnola E, Fioredda F: Prevention of life-threatening infections due to encapsulated
splenomegaly. Scand J Haematol 31:437, 1983. bacteria in children with hyposplenia or asplenia: A brief review of current recommen-
65. Looareesuwan S, Ho M, Wallanagoon Y, et al: Dynamic alteration in splenic function dations for practical purposes. Eur J Haematol 71:319, 2003.
during acute falciparum malaria. N Engl J Med 317: 675, 1987. 96. Guidelines for the prevention and treatment of infection in patients with an absent or
66. Emond AM, Callis R, Darvill D, et al: Acute splenic sequestration in homozygous sickle dysfunctional spleen. BMJ 312:430, 1996.
cell disease: Natural history and management. J Pediatr 107:201, 1985. 97. Davies JM, Barnes R, Milligan D: Update of guidelines for the prevention and treatment
67. Lawrence SE, Pussell BA, Charlesworth JA: Splenic function in primary glomerulone- of infection in patients with an absent or dysfunctional spleen. Clin Med 2:440, 2002.
phritis. Adv Exp Med Biol 641:1, 1982.
68. Webster J, Williams BD, Smith AP, et al: Systemic lupus erythematosus presenting as
pneumococcal septicemia and septic arthritis. Ann Rheum Dis 49:181, 1990.

Kaushansky_chapter 56_p0863-0870.indd 870 9/17/15 3:05 PM